Aaron Dorfman of the National Committee for Responsive Philanthropy argues that foundations need to re-think their strategies and tactics.

A study co-authored by Yale SOM researchers Florian Ederer and Song Ma suggests that “killer acquisitions” by pharmaceutical companies are potentially limiting the number of new treatments available.

A group of Yale SOM researchers examined what kinds of sales incentives lead to profits, and whether longstanding relationships between salespeople and customers are always a good thing.

Yale SOM’s Paul Bracken, an expert on defense strategy, discusses the consequences of a return to a "great power rivalry."

Print isn’t dead yet, but the old model for how to deliver the news might be. Yale Insights talked with New York Times columnist David Leonhardt.

To formulate an optimal product mix, managers need to understand how departmental budgets and information sharing within a company can affect decision making, according to a new study co-authored by Yale SOM’s Rick Antle. 

How will self-driving cars and other new technology reshape the industry? Prof. Jeffrey Sonnenfeld talks with former Ford CEO Mark Fields.

Daniel Weiss ’85, president of the Met, discusses the challenges of changing with the times while preserving the past.